Loading…
for educational and safety purposes
Fladrafinil and Adrafinil both come up in the same conversations; they overlap on Wakefulness. Fladrafinil: Fladrafinil (CRL-40,941) is a synthetic wakefulness drug from the same French research programme of the 1970s and 1980s that produced modafinil and adrafinil; chemically it is adrafinil with a fluorine atom added to each of its two rings. Adrafinil: Adrafinil (CRL-40028) is a prodrug of modafinil and one of the most accessible routes to clean, sustained wakefulness and focus.
Fladrafinil (CRL-40,941) is a synthetic wakefulness drug from the same French research programme of the 1970s and 1980s that produced modafinil and adrafinil; chemically it is adrafinil with a fluorine atom added to each of its two rings. It was never approved or marketed as a medicine anywhere, and it now circulates online as a research chemical and turns up in products sold as nootropic supplements. The body converts it into flmodafinil, which is what actually produces the effect; that conversion has been demonstrated directly in people, but almost nothing else about the drug has been tested in humans. There are no efficacy trials, no safety studies and no published measurement of what it binds to, so claims that it sharpens focus or that it is several times stronger than adrafinil rest on marketing and a 1984 patent rather than on evidence.
Adrafinil (CRL-40028) is a prodrug of modafinil and one of the most accessible routes to clean, sustained wakefulness and focus. Once converted by the liver into modafinil, it delivers the same eugeroic, alertness-promoting effect that made modafinil famous, without requiring a prescription in many countries. Marketed originally in Europe as Olmifon, it remains a favorite among those seeking long-lasting, jitter-light energy and mental stamina.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
weakly inhibits reuptake
weakly inhibits
increases signaling
increases signaling
Fladrafinil is a hydroxamic acid that is hydrolysed in vivo to the corresponding amide, flmodafinil, which carries the pharmacological activity
converts to
activates
processed by
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.
easiest to source: Fladrafinil is currently listed by more trusted vendors (3), so it's the simpler one to get hold of. for effects and safety, read each full entry; this is educational, not medical advice.